Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102349 · ClinicalTrials.gov registry record · Phase 3
HIV and HCV Intervention In Drug Treatment Settings - 1
A Phase 3 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 3
- Development phase
- 706
- Enrollment target
NCT00102349 is a Phase 3 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 706 participants.
The verdict
NCT00102349, a Phase 3 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 706 participants
- Enrollment target
Study Summary
The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
Interventions
- BEHAVIORAL Behavior Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 706 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00102349
The ClinicalTrials.gov registry entry for NCT00102349 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 706 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.
NCT00102349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00102349 about?
NCT00102349 is a clinical study titled "HIV and HCV Intervention In Drug Treatment Settings - 1". The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
What is the current status of trial NCT00102349?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 706 participants. The study started on 2004-11. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00102349?
The interventions under investigation include: Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00102349?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.